Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Anti-Senescence Therapy Revenue 1.4 Market Analysis by Type 1.4.1 Global Anti-Senescence Therapy Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Gene Therapy 1.4.3 Immunotherapy 1.4.4 Others 1.5 Market by Application 1.5.1 Global Anti-Senescence Therapy Market Share by Application: 2020 VS 2026 1.5.2 Cardiovascular Diseases 1.5.3 Neural Degenerative Diseases 1.5.4 Ophthalmology Disorders 1.5.5 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Anti-Senescence Therapy Market Perspective (2015-2026) 2.2 Anti-Senescence Therapy Growth Trends by Regions 2.2.1 Anti-Senescence Therapy Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Anti-Senescence Therapy Historic Market Share by Regions (2015-2020) 2.2.3 Anti-Senescence Therapy Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Anti-Senescence Therapy Market Growth Strategy 2.3.6 Primary Interviews with Key Anti-Senescence Therapy Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Anti-Senescence Therapy Players by Market Size 3.1.1 Global Top Anti-Senescence Therapy Players by Revenue (2015-2020) 3.1.2 Global Anti-Senescence Therapy Revenue Market Share by Players (2015-2020) 3.1.3 Global Anti-Senescence Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Anti-Senescence Therapy Market Concentration Ratio 3.2.1 Global Anti-Senescence Therapy Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Anti-Senescence Therapy Revenue in 2019 3.3 Anti-Senescence Therapy Key Players Head office and Area Served 3.4 Key Players Anti-Senescence Therapy Product Solution and Service 3.5 Date of Enter into Anti-Senescence Therapy Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Anti-Senescence Therapy Historic Market Size by Type (2015-2020) 4.2 Global Anti-Senescence Therapy Forecasted Market Size by Type (2021-2026) 5 Anti-Senescence Therapy Breakdown Data by Application (2015-2026) 5.1 Global Anti-Senescence Therapy Market Size by Application (2015-2020) 5.2 Global Anti-Senescence Therapy Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Anti-Senescence Therapy Market Size (2015-2020) 6.2 Anti-Senescence Therapy Key Players in North America (2019-2020) 6.3 North America Anti-Senescence Therapy Market Size by Type (2015-2020) 6.4 North America Anti-Senescence Therapy Market Size by Application (2015-2020) 7 Europe 7.1 Europe Anti-Senescence Therapy Market Size (2015-2020) 7.2 Anti-Senescence Therapy Key Players in Europe (2019-2020) 7.3 Europe Anti-Senescence Therapy Market Size by Type (2015-2020) 7.4 Europe Anti-Senescence Therapy Market Size by Application (2015-2020) 8 China 8.1 China Anti-Senescence Therapy Market Size (2015-2020) 8.2 Anti-Senescence Therapy Key Players in China (2019-2020) 8.3 China Anti-Senescence Therapy Market Size by Type (2015-2020) 8.4 China Anti-Senescence Therapy Market Size by Application (2015-2020) 9 Japan 9.1 Japan Anti-Senescence Therapy Market Size (2015-2020) 9.2 Anti-Senescence Therapy Key Players in Japan (2019-2020) 9.3 Japan Anti-Senescence Therapy Market Size by Type (2015-2020) 9.4 Japan Anti-Senescence Therapy Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Anti-Senescence Therapy Market Size (2015-2020) 10.2 Anti-Senescence Therapy Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Anti-Senescence Therapy Market Size by Type (2015-2020) 10.4 Southeast Asia Anti-Senescence Therapy Market Size by Application (2015-2020) 11 India 11.1 India Anti-Senescence Therapy Market Size (2015-2020) 11.2 Anti-Senescence Therapy Key Players in India (2019-2020) 11.3 India Anti-Senescence Therapy Market Size by Type (2015-2020) 11.4 India Anti-Senescence Therapy Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Anti-Senescence Therapy Market Size (2015-2020) 12.2 Anti-Senescence Therapy Key Players in Central & South America (2019-2020) 12.3 Central & South America Anti-Senescence Therapy Market Size by Type (2015-2020) 12.4 Central & South America Anti-Senescence Therapy Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Unity Biotechnology 13.1.1 Unity Biotechnology Company Details 13.1.2 Unity Biotechnology Business Overview and Its Total Revenue 13.1.3 Unity Biotechnology Anti-Senescence Therapy Introduction 13.1.4 Unity Biotechnology Revenue in Anti-Senescence Therapy Business (2015-2020)) 13.1.5 Unity Biotechnology Recent Development 13.2 Siwa Therapeutics 13.2.1 Siwa Therapeutics Company Details 13.2.2 Siwa Therapeutics Business Overview and Its Total Revenue 13.2.3 Siwa Therapeutics Anti-Senescence Therapy Introduction 13.2.4 Siwa Therapeutics Revenue in Anti-Senescence Therapy Business (2015-2020) 13.2.5 Siwa Therapeutics Recent Development 13.3 Calico LLC 13.3.1 Calico LLC Company Details 13.3.2 Calico LLC Business Overview and Its Total Revenue 13.3.3 Calico LLC Anti-Senescence Therapy Introduction 13.3.4 Calico LLC Revenue in Anti-Senescence Therapy Business (2015-2020) 13.3.5 Calico LLC Recent Development 13.4 AgeX Therapeutics，Inc 13.4.1 AgeX Therapeutics，Inc Company Details 13.4.2 AgeX Therapeutics，Inc Business Overview and Its Total Revenue 13.4.3 AgeX Therapeutics，Inc Anti-Senescence Therapy Introduction 13.4.4 AgeX Therapeutics，Inc Revenue in Anti-Senescence Therapy Business (2015-2020) 13.4.5 AgeX Therapeutics，Inc Recent Development 13.5 Numeric Biotech 13.5.1 Numeric Biotech Company Details 13.5.2 Numeric Biotech Business Overview and Its Total Revenue 13.5.3 Numeric Biotech Anti-Senescence Therapy Introduction 13.5.4 Numeric Biotech Revenue in Anti-Senescence Therapy Business (2015-2020) 13.5.5 Numeric Biotech Recent Development 13.6 Human Longevity, Inc. (HLI) 13.6.1 Human Longevity, Inc. (HLI) Company Details 13.6.2 Human Longevity, Inc. (HLI) Business Overview and Its Total Revenue 13.6.3 Human Longevity, Inc. (HLI) Anti-Senescence Therapy Introduction 13.6.4 Human Longevity, Inc. (HLI) Revenue in Anti-Senescence Therapy Business (2015-2020) 13.6.5 Human Longevity, Inc. (HLI) Recent Development 13.7 Cleara Biotech 13.7.1 Cleara Biotech Company Details 13.7.2 Cleara Biotech Business Overview and Its Total Revenue 13.7.3 Cleara Biotech Anti-Senescence Therapy Introduction 13.7.4 Cleara Biotech Revenue in Anti-Senescence Therapy Business (2015-2020) 13.7.5 Cleara Biotech Recent Development 13.8 OisinBiotechnologies 13.8.1 OisinBiotechnologies Company Details 13.8.2 OisinBiotechnologies Business Overview and Its Total Revenue 13.8.3 OisinBiotechnologies Anti-Senescence Therapy Introduction 13.8.4 OisinBiotechnologies Revenue in Anti-Senescence Therapy Business (2015-2020) 13.8.5 OisinBiotechnologies Recent Development 13.9 Recursion Pharmaceuticals 13.9.1 Recursion Pharmaceuticals Company Details 13.9.2 Recursion Pharmaceuticals Business Overview and Its Total Revenue 13.9.3 Recursion Pharmaceuticals Anti-Senescence Therapy Introduction 13.9.4 Recursion Pharmaceuticals Revenue in Anti-Senescence Therapy Business (2015-2020) 13.9.5 Recursion Pharmaceuticals Recent Development 13.10 Sierra Sciences 13.10.1 Sierra Sciences Company Details 13.10.2 Sierra Sciences Business Overview and Its Total Revenue 13.10.3 Sierra Sciences Anti-Senescence Therapy Introduction 13.10.4 Sierra Sciences Revenue in Anti-Senescence Therapy Business (2015-2020) 13.10.5 Sierra Sciences Recent Development 13.11 Proteostasis Therapeutics 10.11.1 Proteostasis Therapeutics Company Details 10.11.2 Proteostasis Therapeutics Business Overview and Its Total Revenue 10.11.3 Proteostasis Therapeutics Anti-Senescence Therapy Introduction 10.11.4 Proteostasis Therapeutics Revenue in Anti-Senescence Therapy Business (2015-2020) 10.11.5 Proteostasis Therapeutics Recent Development 13.12 Senolytic Therapeutics 10.12.1 Senolytic Therapeutics Company Details 10.12.2 Senolytic Therapeutics Business Overview and Its Total Revenue 10.12.3 Senolytic Therapeutics Anti-Senescence Therapy Introduction 10.12.4 Senolytic Therapeutics Revenue in Anti-Senescence Therapy Business (2015-2020) 10.12.5 Senolytic Therapeutics Recent Development 13.13 Allergan 10.13.1 Allergan Company Details 10.13.2 Allergan Business Overview and Its Total Revenue 10.13.3 Allergan Anti-Senescence Therapy Introduction 10.13.4 Allergan Revenue in Anti-Senescence Therapy Business (2015-2020) 10.13.5 Allergan Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Anti-Senescence Therapy Key Market Segments Table 2. Key Players Covered: Ranking by Anti-Senescence Therapy Revenue Table 3. Ranking of Global Top Anti-Senescence Therapy Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Anti-Senescence Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Gene Therapy Table 6. Key Players of Immunotherapy Table 7. Key Players of Others Table 8. Global Anti-Senescence Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 9. Global Anti-Senescence Therapy Market Size by Regions (US$ Million): 2020 VS 2026 Table 10. Global Anti-Senescence Therapy Market Size by Regions (2015-2020) (US$ Million) Table 11. Global Anti-Senescence Therapy Market Share by Regions (2015-2020) Table 12. Global Anti-Senescence Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 13. Global Anti-Senescence Therapy Market Share by Regions (2021-2026) Table 14. Market Top Trends Table 15. Key Drivers: Impact Analysis Table 16. Key Challenges Table 17. Anti-Senescence Therapy Market Growth Strategy Table 18. Main Points Interviewed from Key Anti-Senescence Therapy Players Table 19. Global Anti-Senescence Therapy Revenue by Players (2015-2020) (Million US$) Table 20. Global Anti-Senescence Therapy Market Share by Players (2015-2020) Table 21. Global Top Anti-Senescence Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Senescence Therapy as of 2019) Table 22. Global Anti-Senescence Therapy by Players Market Concentration Ratio (CR5 and HHI) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Anti-Senescence Therapy Product Solution and Service Table 25. Date of Enter into Anti-Senescence Therapy Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Anti-Senescence Therapy Market Size by Type (2015-2020) (Million US$) Table 28. Global Anti-Senescence Therapy Market Size Share by Type (2015-2020) Table 29. Global Anti-Senescence Therapy Revenue Market Share by Type (2021-2026) Table 30. Global Anti-Senescence Therapy Market Size Share by Application (2015-2020) Table 31. Global Anti-Senescence Therapy Market Size by Application (2015-2020) (Million US$) Table 32. Global Anti-Senescence Therapy Market Size Share by Application (2021-2026) Table 33. North America Key Players Anti-Senescence Therapy Revenue (2019-2020) (Million US$) Table 34. North America Key Players Anti-Senescence Therapy Market Share (2019-2020) Table 35. North America Anti-Senescence Therapy Market Size by Type (2015-2020) (Million US$) Table 36. North America Anti-Senescence Therapy Market Share by Type (2015-2020) Table 37. North America Anti-Senescence Therapy Market Size by Application (2015-2020) (Million US$) Table 38. North America Anti-Senescence Therapy Market Share by Application (2015-2020) Table 39. Europe Key Players Anti-Senescence Therapy Revenue (2019-2020) (Million US$) Table 40. Europe Key Players Anti-Senescence Therapy Market Share (2019-2020) Table 41. Europe Anti-Senescence Therapy Market Size by Type (2015-2020) (Million US$) Table 42. Europe Anti-Senescence Therapy Market Share by Type (2015-2020) Table 43. Europe Anti-Senescence Therapy Market Size by Application (2015-2020) (Million US$) Table 44. Europe Anti-Senescence Therapy Market Share by Application (2015-2020) Table 45. China Key Players Anti-Senescence Therapy Revenue (2019-2020) (Million US$) Table 46. China Key Players Anti-Senescence Therapy Market Share (2019-2020) Table 47. China Anti-Senescence Therapy Market Size by Type (2015-2020) (Million US$) Table 48. China Anti-Senescence Therapy Market Share by Type (2015-2020) Table 49. China Anti-Senescence Therapy Market Size by Application (2015-2020) (Million US$) Table 50. China Anti-Senescence Therapy Market Share by Application (2015-2020) Table 51. Japan Key Players Anti-Senescence Therapy Revenue (2019-2020) (Million US$) Table 52. Japan Key Players Anti-Senescence Therapy Market Share (2019-2020) Table 53. Japan Anti-Senescence Therapy Market Size by Type (2015-2020) (Million US$) Table 54. Japan Anti-Senescence Therapy Market Share by Type (2015-2020) Table 55. Japan Anti-Senescence Therapy Market Size by Application (2015-2020) (Million US$) Table 56. Japan Anti-Senescence Therapy Market Share by Application (2015-2020) Table 57. Southeast Asia Key Players Anti-Senescence Therapy Revenue (2019-2020) (Million US$) Table 58. Southeast Asia Key Players Anti-Senescence Therapy Market Share (2019-2020) Table 59. Southeast Asia Anti-Senescence Therapy Market Size by Type (2015-2020) (Million US$) Table 60. Southeast Asia Anti-Senescence Therapy Market Share by Type (2015-2020) Table 61. Southeast Asia Anti-Senescence Therapy Market Size by Application (2015-2020) (Million US$) Table 62. Southeast Asia Anti-Senescence Therapy Market Share by Application (2015-2020) Table 63. India Key Players Anti-Senescence Therapy Revenue (2019-2020) (Million US$) Table 64. India Key Players Anti-Senescence Therapy Market Share (2019-2020) Table 65. India Anti-Senescence Therapy Market Size by Type (2015-2020) (Million US$) Table 66. India Anti-Senescence Therapy Market Share by Type (2015-2020) Table 67. India Anti-Senescence Therapy Market Size by Application (2015-2020) (Million US$) Table 68. India Anti-Senescence Therapy Market Share by Application (2015-2020) Table 69. Central & South America Key Players Anti-Senescence Therapy Revenue (2019-2020) (Million US$) Table 70. Central & South America Key Players Anti-Senescence Therapy Market Share (2019-2020) Table 71. Central & South America Anti-Senescence Therapy Market Size by Type (2015-2020) (Million US$) Table 72. Central & South America Anti-Senescence Therapy Market Share by Type (2015-2020) Table 73. Central & South America Anti-Senescence Therapy Market Size by Application (2015-2020) (Million US$) Table 74. Central & South America Anti-Senescence Therapy Market Share by Application (2015-2020) Table 75. Unity Biotechnology Company Details Table 76. Unity Biotechnology Business Overview Table 77. Unity Biotechnology Product Table 78. Unity Biotechnology Revenue in Anti-Senescence Therapy Business (2015-2020) (Million US$) Table 79. Unity Biotechnology Recent Development Table 80. Siwa Therapeutics Company Details Table 81. Siwa Therapeutics Business Overview Table 82. Siwa Therapeutics Product Table 83. Siwa Therapeutics Revenue in Anti-Senescence Therapy Business (2015-2020) (Million US$) Table 84. Siwa Therapeutics Recent Development Table 85. Calico LLC Company Details Table 86. Calico LLC Business Overview Table 87. Calico LLC Product Table 88. Calico LLC Revenue in Anti-Senescence Therapy Business (2015-2020) (Million US$) Table 89. Calico LLC Recent Development Table 90. AgeX Therapeutics，Inc Company Details Table 91. AgeX Therapeutics，Inc Business Overview Table 92. AgeX Therapeutics，Inc Product Table 93. AgeX Therapeutics，Inc Revenue in Anti-Senescence Therapy Business (2015-2020) (Million US$) Table 94. AgeX Therapeutics，Inc Recent Development Table 95. Numeric Biotech Company Details Table 96. Numeric Biotech Business Overview Table 97. Numeric Biotech Product Table 98. Numeric Biotech Revenue in Anti-Senescence Therapy Business (2015-2020) (Million US$) Table 99. Numeric Biotech Recent Development Table 100. Human Longevity, Inc. (HLI) Company Details Table 101. Human Longevity, Inc. (HLI) Business Overview Table 102. Human Longevity, Inc. (HLI) Product Table 103. Human Longevity, Inc. (HLI) Revenue in Anti-Senescence Therapy Business (2015-2020) (Million US$) Table 104. Human Longevity, Inc. (HLI) Recent Development Table 105. Cleara Biotech Company Details Table 106. Cleara Biotech Business Overview Table 107. Cleara Biotech Product Table 108. Cleara Biotech Revenue in Anti-Senescence Therapy Business (2015-2020) (Million US$) Table 109. Cleara Biotech Recent Development Table 110. OisinBiotechnologies Business Overview Table 111. OisinBiotechnologies Product Table 112. OisinBiotechnologies Company Details Table 113. OisinBiotechnologies Revenue in Anti-Senescence Therapy Business (2015-2020) (Million US$) Table 114. OisinBiotechnologies Recent Development Table 115. Recursion Pharmaceuticals Company Details Table 116. Recursion Pharmaceuticals Business Overview Table 117. Recursion Pharmaceuticals Product Table 118. Recursion Pharmaceuticals Revenue in Anti-Senescence Therapy Business (2015-2020) (Million US$) Table 119. Recursion Pharmaceuticals Recent Development Table 120. Sierra Sciences Company Details Table 121. Sierra Sciences Business Overview Table 122. Sierra Sciences Product Table 123. Sierra Sciences Revenue in Anti-Senescence Therapy Business (2015-2020) (Million US$) Table 124. Sierra Sciences Recent Development Table 125. Proteostasis Therapeutics Company Details Table 126. Proteostasis Therapeutics Business Overview Table 127. Proteostasis Therapeutics Product Table 128. Proteostasis Therapeutics Revenue in Anti-Senescence Therapy Business (2015-2020) (Million US$) Table 129. Proteostasis Therapeutics Recent Development Table 130. Senolytic Therapeutics Company Details Table 131. Senolytic Therapeutics Business Overview Table 132. Senolytic Therapeutics Product Table 133. Senolytic Therapeutics Revenue in Anti-Senescence Therapy Business (2015-2020) (Million US$) Table 134. Senolytic Therapeutics Recent Development Table 135. Allergan Company Details Table 136. Allergan Business Overview Table 137. Allergan Product Table 138. Allergan Revenue in Anti-Senescence Therapy Business (2015-2020) (Million US$) Table 139. Allergan Recent Development Table 140. Research Programs/Design for This Report Table 141. Key Data Information from Secondary Sources Table 142. Key Data Information from Primary Sources List of Figures Figure 1. Global Anti-Senescence Therapy Market Share by Type: 2020 VS 2026 Figure 2. Gene Therapy Features Figure 3. Immunotherapy Features Figure 4. Others Features Figure 5. Global Anti-Senescence Therapy Market Share by Application: 2020 VS 2026 Figure 6. Cardiovascular Diseases Case Studies Figure 7. Neural Degenerative Diseases Case Studies Figure 8. Ophthalmology Disorders Case Studies Figure 9. Others Case Studies Figure 10. Anti-Senescence Therapy Report Years Considered Figure 11. Global Anti-Senescence Therapy Market Size YoY Growth 2015-2026 (US$ Million) Figure 12. Global Anti-Senescence Therapy Market Share by Regions: 2020 VS 2026 Figure 13. Global Anti-Senescence Therapy Market Share by Regions (2021-2026) Figure 14. Porter's Five Forces Analysis Figure 15. Global Anti-Senescence Therapy Market Share by Players in 2019 Figure 16. Global Top Anti-Senescence Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Senescence Therapy as of 2019 Figure 17. The Top 10 and 5 Players Market Share by Anti-Senescence Therapy Revenue in 2019 Figure 18. North America Anti-Senescence Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Europe Anti-Senescence Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 20. China Anti-Senescence Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Japan Anti-Senescence Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Southeast Asia Anti-Senescence Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 23. India Anti-Senescence Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Central & South America Anti-Senescence Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Unity Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Unity Biotechnology Revenue Growth Rate in Anti-Senescence Therapy Business (2015-2020) Figure 27. Siwa Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Siwa Therapeutics Revenue Growth Rate in Anti-Senescence Therapy Business (2015-2020) Figure 29. Calico LLC Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Calico LLC Revenue Growth Rate in Anti-Senescence Therapy Business (2015-2020) Figure 31. AgeX Therapeutics，Inc Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. AgeX Therapeutics，Inc Revenue Growth Rate in Anti-Senescence Therapy Business (2015-2020) Figure 33. Numeric Biotech Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Numeric Biotech Revenue Growth Rate in Anti-Senescence Therapy Business (2015-2020) Figure 35. Human Longevity, Inc. (HLI) Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. Human Longevity, Inc. (HLI) Revenue Growth Rate in Anti-Senescence Therapy Business (2015-2020) Figure 37. Cleara Biotech Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. Cleara Biotech Revenue Growth Rate in Anti-Senescence Therapy Business (2015-2020) Figure 39. OisinBiotechnologies Total Revenue (US$ Million): 2019 Compared with 2018 Figure 40. OisinBiotechnologies Revenue Growth Rate in Anti-Senescence Therapy Business (2015-2020) Figure 41. Recursion Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 42. Recursion Pharmaceuticals Revenue Growth Rate in Anti-Senescence Therapy Business (2015-2020) Figure 43. Sierra Sciences Total Revenue (US$ Million): 2019 Compared with 2018 Figure 44. Sierra Sciences Revenue Growth Rate in Anti-Senescence Therapy Business (2015-2020) Figure 45. Proteostasis Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 46. Proteostasis Therapeutics Revenue Growth Rate in Anti-Senescence Therapy Business (2015-2020) Figure 47. Senolytic Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 48. Senolytic Therapeutics Revenue Growth Rate in Anti-Senescence Therapy Business (2015-2020) Figure 49. Allergan Total Revenue (US$ Million): 2019 Compared with 2018 Figure 50. Allergan Revenue Growth Rate in Anti-Senescence Therapy Business (2015-2020) Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation Figure 53. Key Executives Interviewed

Unity Biotechnology Siwa Therapeutics Calico LLC AgeX Therapeutics，Inc Numeric Biotech Human Longevity, Inc. (HLI) Cleara Biotech OisinBiotechnologies Recursion Pharmaceuticals Sierra Sciences Proteostasis Therapeutics Senolytic Therapeutics Allergan